These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15453296)

  • 1. [Mechanism of hepatitis B surface antigen disappearance from and reappearance in the serum of patients with chronic HBV infection].
    Hayashi J; Furusyo N; Nakamuta M; Shimada M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():106-11. PubMed ID: 15453296
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
    Chen J; Wang Z; Zhou B; Wang Y; Hou J
    Antivir Ther; 2012; 17(1):71-9. PubMed ID: 22267471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW; Coyle L; Jones BE; Pattullo V
    Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term history of chronic hepatitis B virus infection in children].
    Fujisawa T; Inui A; Sogo T; Komatsu H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():303-8. PubMed ID: 15453335
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural course and recommendation of therapy for HBV infection].
    Yatsuhashi H; Nagaoka S; Abiru S
    Nihon Shokakibyo Gakkai Zasshi; 2007 Oct; 104(10):1450-8. PubMed ID: 17917392
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Testino G; Borro P; Sumberaz A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
    [No Abstract]   [Full Text] [Related]  

  • 9. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.
    Janssen HL; van Zonneveld M; Senturk H; Zeuzem S; Akarca US; Cakaloglu Y; Simon C; So TM; Gerken G; de Man RA; Niesters HG; Zondervan P; Hansen B; Schalm SW; ;
    Lancet; 2005 Jan 8-14; 365(9454):123-9. PubMed ID: 15639293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis B infection.
    Kuo A; Gish R
    Clin Liver Dis; 2012 May; 16(2):347-69. PubMed ID: 22541703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.
    Su TH; Hsu CS; Chen CL; Liu CH; Huang YW; Tseng TC; Liu CJ; Chen PJ; Lai MY; Chen DS; Kao JH
    Antivir Ther; 2010; 15(8):1133-9. PubMed ID: 21149920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers.
    Kohmoto M; Enomoto M; Tamori A; Habu D; Takeda T; Kawada N; Sakaguchi H; Seki S; Shiomi S; Nishiguchi S
    J Med Virol; 2005 Feb; 75(2):235-9. PubMed ID: 15602726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B reactivation in a renal transplant patient due to a surface antigen mutant strain: a case report.
    Fylaktou A; Daoudaki M; Dimou V; Sianou E; Papaventsis D; Mavrovouniotis I; Fouzas I; Papanikolaou V
    Transplant Proc; 2012 Nov; 44(9):2773-5. PubMed ID: 23146520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection.
    Enomoto M; Nishiguchi S; Tamori A; Kozuka R; Hayashi T; Kohmoto MT; Jomura H; Morikawa H; Murakami Y; Shiomi S; Kawada N
    J Interferon Cytokine Res; 2015 Aug; 35(8):613-20. PubMed ID: 25884105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy.
    Su CW; Wu CY; Hung HH; Wu CH; Sheen IJ; Wu JC
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1849-58. PubMed ID: 23730852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation on the alteration of hepatitis B virus (HBV) markers in liver allograft of HBV related recipients in perioperative period].
    Dai J; Lu SC; Yan LN; Li B; Lai W; Liu J; Zhao J; Wen TF; Gui M; Lin QY; Wang WY; Zhang XH
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):331-3. PubMed ID: 15225422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and selection criteria for chronic hepatitis B].
    Gunji T; Omata M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():309-12. PubMed ID: 15453336
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.